Showing 41 - 50 of 69,939
Persistent link: https://www.econbiz.de/10002435375
Persistent link: https://www.econbiz.de/10001694904
Persistent link: https://www.econbiz.de/10001440699
Persistent link: https://www.econbiz.de/10001526702
complementary biotechnology innovations. Corporate structure and business models of Large Diversificated Firms (LDFs) and Dedicated … Biotechnology Firms (DBFs). In fact, are at the core of scientific research and practice in the management field. We focus our … and Resource Based Views will be underlined and we therefore elaborate on fundamental variables for decision making and …
Persistent link: https://www.econbiz.de/10013100612
Studies strategic alliances between small and large North American biotechnology firms. A strategic alliance (SA) is … executives of selected North American companies: 42 out of 144 dedicated biotechnology companies (DBCs) and 21 out of 70 large … biotechnology firms responded. Additionally, in-depth interviews with some 30 large and small companies investigated SA networks …
Persistent link: https://www.econbiz.de/10013070604
In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …
Persistent link: https://www.econbiz.de/10013224324
Using data on over 900 firms for the period 1988-2000, we estimate the effect on phase-specific biotech and pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the diversification of its experience, and alliances with large and...
Persistent link: https://www.econbiz.de/10013233843
Persistent link: https://www.econbiz.de/10012697092
Persistent link: https://www.econbiz.de/10009736422